Company intelligence / Profile preview

TMJ Health

Ownership: Private
Development stage: Commercial

Overview

TMJ Health developed and commercialized the TMJ NextGeneration™ device, an FDA-cleared, non-invasive ear canal insert designed to reduce pain associated with temporomandibular joint disorders. The product is marketed as safe and effective for reducing jaw pain in patients with TMJD.

Therapeutic areas: Rheumatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on TMJ Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMJ Health.

Explore the full profile